Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Mutant NSCLC

Saved in:
Bibliographic Details
Published inJournal of thoracic oncology Vol. 15; no. 8; pp. e133 - e136
Main Authors Zhou, Huaqiang, Shen, Jiayi, Liu, Jiaqing, Fang, Wenfeng, Zhang, Li
Format Journal Article
LanguageEnglish
Published Elsevier Inc 01.08.2020
Copyright by the International Association for the Study of Lung Cancer
Online AccessGet full text

Cover

Author Fang, Wenfeng
Zhou, Huaqiang
Shen, Jiayi
Liu, Jiaqing
Zhang, Li
AuthorAffiliation Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Peopleʼs Republic of China
AuthorAffiliation_xml – name: Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, Peopleʼs Republic of China
Author_xml – sequence: 1
  givenname: Huaqiang
  orcidid: 0000-0003-3538-4481
  surname: Zhou
  fullname: Zhou, Huaqiang
  organization: Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China
– sequence: 2
  givenname: Jiayi
  surname: Shen
  fullname: Shen, Jiayi
  organization: Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, People’s Republic of China
– sequence: 3
  givenname: Jiaqing
  surname: Liu
  fullname: Liu, Jiaqing
  organization: Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, People’s Republic of China
– sequence: 4
  givenname: Wenfeng
  surname: Fang
  fullname: Fang, Wenfeng
  email: fangwf@sysucc.org.cn
– sequence: 5
  givenname: Li
  surname: Zhang
  fullname: Zhang, Li
  email: zhangli6@mail.sysu.edu.cn
BookMark eNp9kMFqHDEMhk1JoUnaF-hpjr3MRp6xJ17oocuQNgubFprcjaORGW9m7a3tacjb18Pm1ENAQgLp-4X-C3bmgyfGPnNYceDd1X61z2NYNdDACtoS8I6dcym7mrcKzl57UJ34wC5S2gMICUKds2831jo0-FIFW20Ph9lT1Y-ET8fgfK62fnSPLoeYKuer-7vN734j6rs5mzL8ed_v-o_svTVTok-v9ZI9fL956G_r3a8f236zq1EoBTUHqUDStZGWGoO2VWtBAykjEUiswV7LDoWVgx2wo9aaRxwErrFtpSTi7SX7cpI9xvBnppT1wSWkaTKewpx0IxoFXVFVZVWdVjGGlCJZjS6b7ILP0bhJc9CLZ3qvF8_04pmGtgQUtPkPPUZ3MPHlbUicoOcwZYrpaZqfKeqRzJRHDbwRy7P1goACgLpks2BfTxgV1_66QiR05JEGFwmzHoJ76-o_DNuWUQ
CitedBy_id crossref_primary_10_1007_s13691_024_00721_2
crossref_primary_10_1038_s41467_024_54434_4
crossref_primary_10_3390_biom13060984
crossref_primary_10_1111_1759_7714_15098
crossref_primary_10_3390_cells10081920
crossref_primary_10_3390_jcm11226787
crossref_primary_10_1016_j_jtho_2023_08_002
crossref_primary_10_3389_fonc_2024_1399868
crossref_primary_10_1136_jcp_2024_209394
crossref_primary_10_1016_j_compbiomed_2025_109964
crossref_primary_10_2482_haigan_62_345
crossref_primary_10_1016_j_lungcan_2024_108058
crossref_primary_10_1007_s13691_021_00472_4
crossref_primary_10_1016_j_esmoop_2023_101585
crossref_primary_10_3390_jmp2020015
crossref_primary_10_1038_s41416_022_01777_8
crossref_primary_10_3389_fimmu_2021_762598
crossref_primary_10_1200_PO_21_00484
crossref_primary_10_1016_j_pathol_2023_12_414
crossref_primary_10_1016_j_jtho_2020_05_004
crossref_primary_10_1016_j_lungcan_2024_107818
crossref_primary_10_1016_j_esmoop_2024_103472
crossref_primary_10_3389_fonc_2022_916790
Cites_doi 10.1093/annonc/mdz260.105
10.1016/j.jtho.2020.01.002
10.1200/JCO.2017.75.3384
10.1038/s41588-018-0312-8
10.1111/1759-7714.13070
ContentType Journal Article
Copyright 2020 International Association for the Study of Lung Cancer
Copyright © 2020 by the International Association for the Study of Lung Cancer
Copyright_xml – notice: 2020 International Association for the Study of Lung Cancer
– notice: Copyright © 2020 by the International Association for the Study of Lung Cancer
DBID AAYXX
CITATION
7X8
DOI 10.1016/j.jtho.2020.03.030
DatabaseName CrossRef
MEDLINE - Academic
DatabaseTitle CrossRef
MEDLINE - Academic
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1556-1380
EndPage e136
ExternalDocumentID 10_1016_j_jtho_2020_03_030
01243894-202008000-00020
S1556086420302951
GroupedDBID ---
.55
.XZ
.Z2
0R~
0SF
457
53G
5GY
5VS
6I.
AACTN
AAEDW
AAFTH
AAIAV
AAKAS
AALRI
AAWTL
AAXUO
ABBUW
ABJNI
ABMAC
ABPMR
ABVKL
ACDDN
ACGFS
ACWDW
ACWRI
ADBBV
ADBIZ
ADEZE
ADZCM
AE3
AENEX
AEXQZ
AFTJW
AFTRI
AGHFR
AITUG
AIZYK
AKRWK
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
AWKKM
BOYCO
C45
CS3
DU5
E.X
EBS
EJD
EX3
F5P
FDB
FL-
HZ~
IN~
KD2
NCXOZ
NTWIH
O9-
OFXIZ
OGEVE
OK1
OVD
P2P
ROL
S4S
SSZ
TEORI
V2I
W3M
WOQ
WOW
X7M
AAYWO
ADVLN
AFETI
AFJKZ
AGCQF
APXCP
AAYXX
ACVFH
ADCNI
AEUPX
AFPUW
AIGII
AKBMS
AKYEP
CITATION
7X8
ID FETCH-LOGICAL-c4880-105805e7a5fe2acf3894ede8a5c0e490f756c4f5dfdc6e3fabcd4c9c3355ee13
ISSN 1556-0864
1556-1380
IngestDate Thu Jul 10 19:08:31 EDT 2025
Tue Jul 01 02:57:10 EDT 2025
Thu Apr 24 23:05:48 EDT 2025
Fri May 16 03:53:29 EDT 2025
Thu Jun 13 14:30:57 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c4880-105805e7a5fe2acf3894ede8a5c0e490f756c4f5dfdc6e3fabcd4c9c3355ee13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correspondence-1
ObjectType-Commentary-3
content type line 23
ORCID 0000-0003-3538-4481
OpenAccessLink http://www.jto.org/article/S1556086420302951/pdf
PQID 2428063898
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2428063898
crossref_citationtrail_10_1016_j_jtho_2020_03_030
crossref_primary_10_1016_j_jtho_2020_03_030
wolterskluwer_health_01243894-202008000-00020
elsevier_sciencedirect_doi_10_1016_j_jtho_2020_03_030
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate August 2020
2020-August
2020-08-00
20200801
PublicationDateYYYYMMDD 2020-08-01
PublicationDate_xml – month: 08
  year: 2020
  text: August 2020
PublicationDecade 2020
PublicationTitle Journal of thoracic oncology
PublicationYear 2020
Publisher Elsevier Inc
Copyright by the International Association for the Study of Lung Cancer
Publisher_xml – name: Elsevier Inc
– name: Copyright by the International Association for the Study of Lung Cancer
References Dagogo-Jack, Schrock, Kem (bib2) 2020; 15
Graziano, Lin, Elvin (bib1) 2019; 30
Samstein, Lee, Shoushtari (bib4) 2019; 51
Naito, Umemura, Nakamura (bib5) 2019; 10
Rizvi, Sanchez-Vega, La (bib3) 2018; 36
Graziano (10.1016/j.jtho.2020.03.030_bib1) 2019; 30
Dagogo-Jack (10.1016/j.jtho.2020.03.030_bib2) 2020; 15
Samstein (10.1016/j.jtho.2020.03.030_bib4) 2019; 51
Rizvi (10.1016/j.jtho.2020.03.030_bib3) 2018; 36
Naito (10.1016/j.jtho.2020.03.030_bib5) 2019; 10
References_xml – volume: 36
  start-page: 633
  year: 2018
  end-page: 641
  ident: bib3
  article-title: Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
  publication-title: J Clin Oncol
– volume: 10
  start-page: 1285
  year: 2019
  end-page: 1288
  ident: bib5
  article-title: Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: a case report
  publication-title: Thorac Cancer
– volume: 30
  start-page: v652
  year: 2019
  end-page: v653
  ident: bib1
  article-title: SMARCA4 deficient non-small cell lung cancer (NSCLC): a comprehensive genomic profiling (CGP) study
  publication-title: Ann Oncol
– volume: 15
  start-page: 766
  year: 2020
  end-page: 776
  ident: bib2
  article-title: Clinicopathologic characteristics of BRG1-deficient NSCLC
  publication-title: J Thorac Oncol
– volume: 51
  start-page: 202
  year: 2019
  end-page: 206
  ident: bib4
  article-title: Tumor mutational load predicts survival after immunotherapy across multiple cancer types
  publication-title: Nat Genet
– volume: 30
  start-page: v652
  year: 2019
  ident: 10.1016/j.jtho.2020.03.030_bib1
  article-title: SMARCA4 deficient non-small cell lung cancer (NSCLC): a comprehensive genomic profiling (CGP) study
  publication-title: Ann Oncol
  doi: 10.1093/annonc/mdz260.105
– volume: 15
  start-page: 766
  year: 2020
  ident: 10.1016/j.jtho.2020.03.030_bib2
  article-title: Clinicopathologic characteristics of BRG1-deficient NSCLC
  publication-title: J Thorac Oncol
  doi: 10.1016/j.jtho.2020.01.002
– volume: 36
  start-page: 633
  year: 2018
  ident: 10.1016/j.jtho.2020.03.030_bib3
  article-title: Molecular determinants of response to anti-programmed cell death (PD)-1 and anti-programmed death-ligand 1 (PD-L1) blockade in patients with non-small-cell lung cancer profiled with targeted next-generation sequencing
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.2017.75.3384
– volume: 51
  start-page: 202
  year: 2019
  ident: 10.1016/j.jtho.2020.03.030_bib4
  article-title: Tumor mutational load predicts survival after immunotherapy across multiple cancer types
  publication-title: Nat Genet
  doi: 10.1038/s41588-018-0312-8
– volume: 10
  start-page: 1285
  year: 2019
  ident: 10.1016/j.jtho.2020.03.030_bib5
  article-title: Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: a case report
  publication-title: Thorac Cancer
  doi: 10.1111/1759-7714.13070
SSID ssj0045048
Score 2.4220679
SourceID proquest
crossref
wolterskluwer
elsevier
SourceType Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage e133
Title Efficacy of Immune Checkpoint Inhibitors in SMARCA4-Mutant NSCLC
URI https://dx.doi.org/10.1016/j.jtho.2020.03.030
https://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=01243894-202008000-00020
https://www.proquest.com/docview/2428063898
Volume 15
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBZbCmMwxq4s3QUP9hY8FEfy5W0htJSV9KHLaNmLkHWZ1Q67XW3K9ut3JMt20rVlHQTjCFvYOp_O-SSfC0IfMiGnOBMiJMDcQpLGEvQgnEkwJjLiucpcnoLlQbz3lXw-pseDu62LLqnzj-L3tXEl_yNVaAO52ijZO0i27xQa4BzkC0eQMBz_ScY7Nv-Drddu40FsoIeaLAolTs8qU9Yw9QuTG1dNx8AkXs4PF3MSLhtbN3hy8GXhywX_zUzrAnAhjJhUpdjYdf9WVI2zVQ0_B1h977dnuhAPw3-Z3sXHNL7t3AyX7vr96SNVauWb_aZDNLi89XqSxtDWJiDvFSldA0y6phXVtE124S0s_I2v1d7tRsIJvHhh4zIj7PLP-u82G6myr5iw3rGw81k7YbYPZvtgeAY_fB9tRbCSiEZoa75_eLTfmWtCsSux1r-Rj6xqnQCvPslN7GVtdfLosrJ-DhenLsxhjaysnqDHXpbBvIXMU3RPlc_Qg6X3o3iOPnXICSodtMgJBuQEA3ICUwabyAkccl6g1e7OarEX-loaobAqGqwtTTFVCadaRVxo4KlESZVyKrAiGdYJjQXRVGopYjXTPBeSiEzMgI8qENhLNCqrUr1CgaKpzGzeQY05kWmU8UQkEc50RLiWMhmjaTdETPg887bcyQ92s3DGaNLfc9ZmWbn1atqNPPM8seV_DIB0633vOzExUKL2yxgvVdVcMOCpqePu6RiFG_JjbTgyAx5H7JiFtj-7ynL5GCK8facnf40eDrPpDRrVPxv1Fkhtnb_zsPwDrwudng
linkProvider Library Specific Holdings
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Efficacy+of+Immune+Checkpoint+Inhibitors+in+SMARCA4-Mutant+NSCLC&rft.jtitle=Journal+of+thoracic+oncology&rft.au=Zhou%2C+Huaqiang&rft.au=Shen%2C+Jiayi&rft.au=Liu%2C+Jiaqing&rft.au=Fang%2C+Wenfeng&rft.date=2020-08-01&rft.issn=1556-0864&rft.volume=15&rft.issue=8&rft.spage=e133&rft.epage=e136&rft_id=info:doi/10.1016%2Fj.jtho.2020.03.030&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_jtho_2020_03_030
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1556-0864&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1556-0864&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1556-0864&client=summon